Skip to content

Medical Need of OAC Reversal

Medical Need of Oral Anti-coagulant Reversal in Japan: Epidemiological Assessment of Head Trauma, Fracture, and Emergency Surgery Using Large Scale Claims Database (Please Note That This Study Contains no Patients Treated With Idarucizumab Although the Study Number Begins With 1321; the Study Contains Only Patients Treated With OACs, Namely Warfarin, Dabigatran, Edoxaban, Apixaban, Rivaroxaban, Edoxaban)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03254147
Enrollment
53969
Registered
2017-08-18
Start date
2017-10-15
Completion date
2017-11-10
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

This is a retrospective, observational, claims cohort study to assess, for adult patients initiating an oral anticoagulant for NVAF

Detailed description

This is a retrospective, observational, claims cohort study to assess, for adult patients initiating an oral anticoagulant for NVAF, the incidence rates of emergency surgery, major bleeding due to trauma, and major bleeding due to fracture, overall and stratified by age (\<64, 65-74, \>75). The secondary objective is to estimate the overall and age stratified incidence of cardiac tamponade and peri-cardiocentesis.

Interventions

DRUGwarfarin

warfarin

DRUGdabigatran

Non-vitamin K dependent oral anti-coagulants (NOACs)

DRUGApixaban

Non-vitamin K dependent oral anti-coagulants (NOACs)

DRUGEdoxaban

Non-vitamin K dependent oral anti-coagulants (NOACs)

DRUGRivaroxaban

Non-vitamin K dependent oral anti-coagulants (NOACs)

Sponsors

Boehringer Ingelheim
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-\>18 year old non-valvular atrial fibrillation (NVAF) patients * Prescribed dabigatran, rivaroxaban, apixaban, edoxaban or warfarin * Patients with confirmed date of initiation of OACs * Patients with a minimum of 6 months of enrolment data prior to index date * Has an index date between 14th of March 2011 to 30 June, 2016

Exclusion criteria

* Patients receiving two or more oral anti-coagulants at the same time at index date * Patients with prescriptions of index treatment in the 6 months prior to index date * Patients without enrolment period of at least six month in the database

Design outcomes

Primary

MeasureTime frameDescription
The Number of Patients With Emergency Surgery and Major Bleeding Due to Fracture or Trauma.One yearThe number of patients with emergency surgery and major bleeding due to fracture or trauma. Where emergency surgery defined as any surgical procedure (International Classification of Diseases (ICD) 10 code K000-879) performed on the same day as hospital admission with additional claims, major bleeding due to fracture is any bleeding associated with hospitalization or blood transfusion (ICD10 code E83.111) accompanied by any fracture, and major bleeding due to trauma is any bleeding associated with hospitalization or blood transfusion (ICD10 code E83.111) accompanied by any trauma.

Secondary

MeasureTime frameDescription
The Number of Patients With Cardiac Tamponade and Pericardiocentesis.One yearThe number of patients with cardiac tamponade and pericardiocentesis. Cardiac tamponade diagnosis (ICD 10 code 4200001) on the same or next day as catheter ablation or percutaneous coronary intervention (PCI), Pericardiocentesis (Medical Data Vision (MDV) procedure code 140010510) on the same or next day as catheter ablation or PCI.

Countries

Japan

Participant flow

Recruitment details

Non-interventional study based on existing health insurance claims data

Pre-assignment details

All patients were screened for eligibility to participate in the trial. Patients met all strictly implemented inclusion/exclusion criteria. Patients were not to be entered to trial if any one of the specific entry criteria was violated.

Participants by arm

ArmCount
Patients Prescribed With Non-warfarin Oral Anti Coagulants
Patients prescribed with Non-warfarin Oral Anti Coagulants (NOACs) (dabigatran, rivaroxaban, apixaban, edoxaban) or warfarin were grouped as a single exposure group and analysed as a whole. On treatment duration was expressed in patient year for the follow-up duration to calculate the incidence of various clinical events during the on-treatment duration.
53,969
Total53,969

Baseline characteristics

CharacteristicPatients Prescribed With Non-warfarin Oral Anti Coagulants
Age, Continuous76 Years
STANDARD_DEVIATION 10
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53969 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
53969 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
21587 Participants
Sex: Female, Male
Male
32382 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

The Number of Patients With Emergency Surgery and Major Bleeding Due to Fracture or Trauma.

The number of patients with emergency surgery and major bleeding due to fracture or trauma. Where emergency surgery defined as any surgical procedure (International Classification of Diseases (ICD) 10 code K000-879) performed on the same day as hospital admission with additional claims, major bleeding due to fracture is any bleeding associated with hospitalization or blood transfusion (ICD10 code E83.111) accompanied by any fracture, and major bleeding due to trauma is any bleeding associated with hospitalization or blood transfusion (ICD10 code E83.111) accompanied by any trauma.

Time frame: One year

Population: Results are based on the number of patients meeting the inclusion and exclusion criteria.

ArmMeasureGroupValue (NUMBER)
Patients Prescribed With Non-warfarin Oral Anti CoagulantsThe Number of Patients With Emergency Surgery and Major Bleeding Due to Fracture or Trauma.Age <=6414 Number of Patients
Patients Prescribed With Non-warfarin Oral Anti CoagulantsThe Number of Patients With Emergency Surgery and Major Bleeding Due to Fracture or Trauma.Age 65-7435 Number of Patients
Patients Prescribed With Non-warfarin Oral Anti CoagulantsThe Number of Patients With Emergency Surgery and Major Bleeding Due to Fracture or Trauma.Age >=7584 Number of Patients
Secondary

The Number of Patients With Cardiac Tamponade and Pericardiocentesis.

The number of patients with cardiac tamponade and pericardiocentesis. Cardiac tamponade diagnosis (ICD 10 code 4200001) on the same or next day as catheter ablation or percutaneous coronary intervention (PCI), Pericardiocentesis (Medical Data Vision (MDV) procedure code 140010510) on the same or next day as catheter ablation or PCI.

Time frame: One year

Population: Results are based on the number of patients meeting the inclusion and exclusion criteria.

ArmMeasureValue (NUMBER)
Patients Prescribed With Non-warfarin Oral Anti CoagulantsThe Number of Patients With Cardiac Tamponade and Pericardiocentesis.1 Number of Patients

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026